The why and wherefore of hepatic encephalopathy

References

• American Association for the Study of Liver, European Association for the Study of the LiverHepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the study of the liver and the American Association for the study of liver diseasesJ Hepatol201461364265925015420
   PubMed Web of Science ®Google Scholar
• VilstrupHAmodioPBajajJHepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the study of liver diseases and the European Association for the study of the liverHepatology201460271573525042402
   PubMed Web of Science ®Google Scholar
• HäussingerDSchliessFPathogenetic mechanisms of hepatic encephalopathyGut20085781156116518628377
   PubMed Web of Science ®Google Scholar
• MontagneseSAmodioPMorganMYMethods for diagnosing hepatic encephalopathy in patients with cirrhosis: a multidimensional approachMetab Brain Dis200419328131215554423
   PubMed Web of Science ®Google Scholar
• ButterworthRFPathophysiology of hepatic encephalopathy: a new look at ammoniaMetab Brain Dis200217422122712602499
   PubMed Web of Science ®Google Scholar
• ShawcrossDJalanRThe pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammationCell Mol Life Sci200562192295230416158192
   PubMed Web of Science ®Google Scholar
• HahnMMassenONenckiMPavlovIDie Eck’sche fistel zwischen der unteren hohlvene und der pfortader und ihre folgen fur den organismusArch Exp Pathol Pharm189332161210
   Google Scholar
• NenckiMPawlowJPZalenskiJUeber den ammoniakgehalt des blutes und der organe und die harnstoff- bildung bei den saugethieren [On the subject of ammonia content of blood and organs and urea formation in mammals]Archiv Fuer Experimentelle Pathologie und Pharmakologie1896372651 German
   Google Scholar
• GabuzdaGPhillipsGDavidsonCReversible toxic manifestations in patients with cirrhosis of the liver given cation-exchange resinsN Engl J Med1952246412413014890821
   PubMed Web of Science ®Google Scholar
• ButterworthRGiguèreJMichaudJLavoieJLayrarguesGAmmonia: key factor in the pathogenesis of hepatic encephalopathyNeurochem Pathol198761–21123306479
   PubMedGoogle Scholar
• GregoriosJMozesLNorenbergMMorphologic effects of ammonia on primary astrocyte cultures. II. Electron microscopic studiesJ Neuropathol Exp Neurol19854444044144040156
   PubMed Web of Science ®Google Scholar
• ChenSMahadevanVZieveLVolatile fatty acids in the breath of patients with cirrhosis of the liverJ Lab Clin Med19707546226275444347
   PubMed Web of Science ®Google Scholar
• ZieveLDoizakiWMZieveJSynergism between mercaptans and ammonia or fatty acids in the production of coma: a possible role for mercaptans in the pathogenesis of hepatic comaJ Lab Clin Med197483116284808653
   PubMed Web of Science ®Google Scholar
• MorganMBoltonCMorrisJReadAMedium chain triglycerides and hepatic encephalopathyGut19741531801844841275
   PubMed Web of Science ®Google Scholar
• FischerJYoshimuraNAguirreAPlasma amino acids in patients with hepatic encephalopathyAm J Surg1974127140474808685
   PubMed Web of Science ®Google Scholar
• IberFLRosenHLevensonSMChalmersTCThe plasma amino acids in patients with liver failureJ Lab Clin Med195750341742513463457
   PubMed Web of Science ®Google Scholar
• SoetersPWeirGEbeidAFischerJInsulin, glucagon, portal systemic shunting, and hepatic failure in the dogJ Surg Res1977233183188886853
   PubMed Web of Science ®Google Scholar
• CurzonGKantamaneniBFernandoJWoodsMCavanaghJEffects of chronic porto-caval anastomosis on brain tryptophan, tyrosine and 5-hydroxytryptamineJ Neurochem1975245106510701141890
   PubMed Web of Science ®Google Scholar
• MoroniFLombardiGMonetiGCortesiniCThe release and neosynthesis of glutamic acid are increased in experimental models of hepatic encephalopathyJ Neurochem19834038508546131108
   PubMed Web of Science ®Google Scholar
• RaabeWSynaptic transmission in ammonia intoxicationNeurochem Pathol198761–21451662819792
   PubMedGoogle Scholar
• HouraniBCerebrospinal fluid glutamine as a measure of hepatic encephalopathyArch Intern Med1971127610335578559
   PubMedGoogle Scholar
• BasileAJonesEAmmonia and GABA-ergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathyHepatology1997256130313059185743
   PubMed Web of Science ®Google Scholar
• LevyLJLeekJLosowskyMSEvidence for gamma-aminobutyric acid as the inhibitor of gamma-aminobutyric acid binding in the plasma of humans with liver disease and hepatic encephalopathyClin Sci (Lond)19877355315343677559
   PubMed Web of Science ®Google Scholar
• SherlockSDooleyJDiseases of the Liver and Biliary System11 edOxfordBlackwell Science2002
   Google Scholar
• AnholtRRPedersenPLDe SouzaEBSnyderSHThe peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membraneJ Biol Chem198626125765833001071
   PubMed Web of Science ®Google Scholar
• BanatiRVisualising microglial activation in vivoGlia200240220621712379908
   PubMed Web of Science ®Google Scholar
• ItzhakYNorenbergMAmmonia-induced upregulation of peripheral-type benzodiazepine receptors in cultured astrocytes labeled with [3H] PK 11195Neurosci Lett19941771–235387824177
   PubMed Web of Science ®Google Scholar
• LavoieJLayrarguesGButterworthRIncreased densities of peripheral-type benzodiazepine receptors in brain autopsy samples from cirrhotic patients with hepatic encephalopathyHepatology19901158748782161396
   PubMed Web of Science ®Google Scholar
• CagninATaylor-RobinsonSDFortonDMBanatiRBIn vivo imaging of cerebral “peripheral benzodiazepine binding sites” in patients with hepatic encephalopathyGut200655454755316210399
   PubMed Web of Science ®Google Scholar
• ShawcrossDWrightGOlde DaminkSJalanRRole of ammonia and inflammation in minimal hepatic encephalopathyMetab Brain Dis200722112513817260161
   PubMed Web of Science ®Google Scholar
• LiuQDuanZHaDBengmarkSKurtovicJRiordanSSynbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosisHepatology20043951441144915122774
   PubMed Web of Science ®Google Scholar
• HäussingerDKircheisGFischerRSchliessFDahlSHepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema?J Hepatol20003261035103810898326
   PubMed Web of Science ®Google Scholar
• HäussingerDLaubenbergerJvom DahlSProton magnetic resonance spectroscopy studies on human brain Myo-inositol in hypoosmolarity and hepatic encephalopathyGastroenterology19941075147514807926510
   PubMed Web of Science ®Google Scholar
• Parsons-SmithBSummerskillWDawsonASherlockSThe electroencephalograph in liver diseaseLancet1957270700186787113482229
   PubMed Web of Science ®Google Scholar
• ConnHOLeevyCMVlahcevicZRComparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trialGastroenterology1977724 pt 157358314049
   PubMed Web of Science ®Google Scholar
• ZeegenRDrinkwaterJDawsonAMethod for measuring cerebral dysfunction in patients with liver diseaseBMJ1970257106336365429105
   PubMed Web of Science ®Google Scholar
• RikkersLJenkoPRudmanDFreidesDSubclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolismGastroenterology1978753462469680502
   PubMed Web of Science ®Google Scholar
• TarterREHegedusAMVan ThielDHSchadeRRGavalerJSStarzlTENonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathyGastroenterology1984866142114276714571
   PubMed Web of Science ®Google Scholar
• FerenciPHepatic encephalopathy – definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998Hepatology200235371672111870389
   PubMed Web of Science ®Google Scholar
• GroenewegMQueroJCDe BruijnISubclinical hepatic encephalopathy impairs daily functioningHepatology199828145499657095
   PubMed Web of Science ®Google Scholar
• BergnerMBobbittRCarterWGilsonBThe sickness impact profile: development and final revision of a health status measureMed Care19811987878057278416
   PubMed Web of Science ®Google Scholar
• SchomerusHHamsterWQuality of life in cirrhotics with minimal hepatic encephalopathyMetab Brain Dis2001161–2374111726087
   PubMed Web of Science ®Google Scholar
• WeinCKochHPoppBOehlerGSchauderPMinimal hepatic encephalopathy impairs fitness to driveHepatology200439373974514999692
   PubMed Web of Science ®Google Scholar
• BajajJHafeezullahMHoffmannRSaeianKMinimal hepatic encephalopathy: a vehicle for accidents and traffic violationsAm J Gastroenterol200710291903190917640323
   PubMed Web of Science ®Google Scholar
• GroenewegMMoerlandWQueroJHopWKrabbePSchalmSScreening of subclinical hepatic encephalopathyJ Hepatol200032574875310845661
   PubMed Web of Science ®Google Scholar
• SoodGKSarinSKMahaptraJBroorSLComparative efficacy of psychometric tests in detection of subclinical hepatic encephalopathy in nonalcoholic cirrhotics: search for a rational approachAm J Gastroenterol19898421561592916526
   PubMed Web of Science ®Google Scholar
• MarchesiniGZoliMDondiCPrevalence of subclinical hepatic encephalopathy in cirrhotics and relationship to plasma amino acid imbalanceDigest Dis Sci198025107637687428585
   PubMed Web of Science ®Google Scholar
• WeissenbornKEnnenJSchomerusHRückertNHeckerHNeuropsychological characterization of hepatic encephalopathyJ Hepatol200134576877311434627
   PubMed Web of Science ®Google Scholar
• ReitanRThe relation of the trail making test to organic brain damageJ Consult Psychol195519539339413263471
   PubMedGoogle Scholar
• WechslerDWechsler Adult Intelligence Scale – RevisedNew YorkPsychological Corporation1981
   Google Scholar
• Romero GómezMCórdobaJJoverRNormality tables in the spanish population for psychometric tests used in the diagnosis of minimal hepatic encephalopathyMed Clin (Barc)2006127724624916942726
   PubMed Web of Science ®Google Scholar
• AmodioPCampagnaFOlianasSDetection of minimal hepatic encephalopathy: normalization and optimization of the psychometric hepatic encephalopathy score. A neuropsychological and quantified EEG studyJ Hepatol200849334635318602716
   PubMed Web of Science ®Google Scholar
• LearmonthYDlugonskiDPiluttiLSandroffBKlarenRMotlRPsychometric properties of the fatigue severity scale and the modified fatigue impact scaleJ Neurol Sci20133311–210210723791482
   PubMed Web of Science ®Google Scholar
• PrcicAAganovicDHadziosmanovicOSickness impact profile (SIP) score, a good alternative instrument for measuring quality of life in patients with ileal urinary diversionsActa Informatica Medica201321316024167383
   PubMedGoogle Scholar
• TreanorCDonnellyMA methodological review of the short form health survey 36 (SF-36) and its derivatives among breast cancer survivorsQual Life Res201524233936225139502
   PubMed Web of Science ®Google Scholar
• SchatzPBrowndykeJApplications of computer-based neuropsychological assessmentJ Head Trauma Rehabil200217539541012802251
   PubMed Web of Science ®Google Scholar
• TartaglioneEVDerlethMYuLIoannouGNCan computerized brain training games be used to identify early cognitive impairment in cirrhosis?Am J Gastroenterol2014109331632324594947
   PubMed Web of Science ®Google Scholar
• FoleyJMWatsonCWAdamsRDSignificance of the electroencephalographic changes in hepatic comaTrans Am Neurol Assoc19505116116514788100
   PubMedGoogle Scholar
• KircheisGCritical flicker frequency for quantification of low-grade hepatic encephalopathyHepatology200235235736611826409
   PubMed Web of Science ®Google Scholar
• GroverVPDresnerMAFortonDMCurrent and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathyWorld J Gastroenterol200612192969297816718775
   PubMed Web of Science ®Google Scholar
• TimmermannLButzMGrossJImpaired cerebral oscillatory processing in hepatic encephalopathyNeurophysiol Clin20081192265272
   Web of Science ®Google Scholar
• DawsonANeomycin in the treatment of hepatic comaLancet1957270700812631268
   Google Scholar
• FerenciPHernethASteindlPNewer approaches to therapy of hepatic encephalopathySemin Liver Dis199616033293388989818
   PubMed Web of Science ®Google Scholar
• AdachiJDuPontHRifaximin: a novel nonabsorbed rifamycin for gastrointestinal disordersClin Infect Dis200642454154716421799
   PubMed Web of Science ®Google Scholar
• de MeloRCharneskiLHilasORifaximin for the treatment of hepatic encephalopathyAm J Health-Syst Pharm200865981882218436728
   PubMed Web of Science ®Google Scholar
• BassNMMullenKDSanyalARifaximin treatment in hepatic encephalopathyN Engl J Med2010362121071108120335583
   PubMed Web of Science ®Google Scholar
• KimerNKragAMollerSBendtsenFGluudLLSystematic review with meta-analysis: the effects of rifaximin in hepatic encephalopathyAliment Pharmacol Ther201440212313224849268
   PubMed Web of Science ®Google Scholar
• BircherJMüllerJGuggenheimPHaemmerliUTreatment of chronic portal-systemic encephalopathy with lactuloseLancet196628774438908934159616
   PubMed Web of Science ®Google Scholar
• WeberFLJrBanwellJGFresardKMCummingsJHNitrogen in fecal bacterial, fiber, and soluble fractions of patients with cirrhosis: effects of lactulose and lactulose plus neomycinJ Lab Clin Med198711032592633611949
   PubMed Web of Science ®Google Scholar
• ButterworthRRoseCQuackGKircheisGl-Ornithine-l-aspartate in experimental portal-systemic encephalopathy: therapeutic efficacy and mechanism of actionJ Hepatol199828709537866
   PubMed Web of Science ®Google Scholar
• ReesCEffect of l-ornithine-l-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trialGut200047457157410986219
   PubMed Web of Science ®Google Scholar
• PooJLGóngoraJSánchez-AvilaFEfficacy and safety of l-ornithine-l-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathyAnn Hepatol20065428128817151582
   PubMedGoogle Scholar
• JiangQJiangXZhengMChenYl-Ornithine-l-aspartate in the management of hepatic encephalopathy: a meta-analysisJ Gastroenterol Hepatol200924191418823442
   PubMed Web of Science ®Google Scholar
• PrakashRMullenKMechanisms, diagnosis and management of hepatic encephalopathyNat Rev Gastroenterol Hepatol20107951552520703237
   PubMed Web of Science ®Google Scholar
• RiordanSMWilliamsRTreatment of hepatic encephalopathyN Engl J Med199733774734799250851
   PubMed Web of Science ®Google Scholar
• ShuklaSShuklaAMehboobSGuhaSMeta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathyAliment Pharmacol Ther201133666267121251030
   PubMed Web of Science ®Google Scholar
• MutoYSatoSWatanabeAEffects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosisClin Gastroenterol Hepatol20053770571316206505
   PubMed Web of Science ®Google Scholar
• Als-NielsenBKoretzRLKjaergardLLGluudCBranched-chain amino acids for hepatic encephalopathyCochrane Database Syst Rev20032CD00193912804416
   PubMedGoogle Scholar
• NeubergerJGimsonADaviesMSelection of patients for liver transplantation and allocation of donated livers in the UKGut200757225225717895356
   PubMed Web of Science ®Google Scholar